Junior Hall

发表

Targeting Notch signaling in autoimmune and lymphoproliferative disease.

D. Teachey, C. Sheen, J. Hall, 2008, Blood.

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

M. Loh, D. Teachey, J. Hall, 2015, Blood.

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

K. Sullivan, J. Maris, D. Teachey, 2006, Blood.

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

D. Teachey, C. Sheen, J. Hall, 2008, Blood.

Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.

M. Loh, D. Teachey, C. Sheen, 2012, Blood.

Targeting JAK 1 / 2 and mTOR in Murine Xenograft Models of Ph-like Acute Lymphoblastic Leukemia ( ALL )

M. Loh, D. Teachey, C. Sheen, 2012 .

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

D. Teachey, T. Ryan, S. Grupp, 2015, Blood.

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

K. Sullivan, J. Maris, D. Teachey, 2006, Blood.

Targeting mTOR and JAK2 in Xenograft Models of CRLF2-Overexpressing Acute Lymphoblastic Leukemia (ALL)

D. Teachey, S. Grupp, C. Mullighan, 2011 .